retatrutide joint pain (Eli Lilly's triple GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the phase 3 TRIUMPH-4 trial: Once-Weekly Retatrutide Reduces Weight and

were contacted

To investigate this possibility, HRTV protein sequences were retrieved from UniProt and NCBI, and their predicted 3D structures were generated using SWISS-MODEL

You may see claims that berberine boosts GLP-1. Some preclinical work suggests gut-hormone changes may happen, but even if that is true, it is not the same magnitude or reliability as a prescription GLP-1 agonist

"So these conversations have been in my therapy room for several years now and they certainly do affect how treatment unfolds." The idea of using a weight loss drug could occur at a "pretty fragile time", she said, with potentially dangerous consequences

The recommended dosage is two tablets daily

Gastrointestinal adverse events were again among the most frequently reported findings